Real world evidence supports waking salivary cortisone as a screening test for adrenal insufficiency
Clinical Endocrinology · 2023
DOI: 10.1111/cen.14975 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2023. Verfasst von Miguel Debono und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Hauptthemen laut MEDLINE: Cortisone, Adrenal Insufficiency. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Council, Department of Health.
Abstract (Originalsprache)
Objective
Worldwide, adults and children are at risk of adrenal insufficiency largely due to infectious diseases and adrenal suppression from use of anti‐inflammatory glucocorticoids. Home waking salivary cortisone is an accurate screening test for adrenal insufficiency, it has potential to reduce costs, and patients prefer it to the adrenocorticotropin (ACTH) (synacthen) stimulation test. We carried out a service evaluation of home waking salivary cortisone in clinical care to identify implementation barriers. Design, Patients and Measurements Service evaluation in a centre where 212 patients referred for adrenal insufficiency had a waking salivary cortisone. Problems encountered during testing were recorded and patient feedback, via focus groups, collected.
Results
From all patients providing a waking salivary cortisone 55% had a normal test, 23% adrenal suppression, and 22% an equivocal result requiring a clinical centre ACTH stimulation test. The median (interquartile range [IQR]) for the time of the saliva sample was 07:40 (07:00–08:40). The median (IQR) days between collection and (i) delivery to local laboratory was 1 (0.25–2) day; (ii) reporting by local laboratory was 13 (11–18) days. Patients considered the test is “easy to do” and preferred it to the inpatient ACTH stimulation test. The principal challenge to clinical implementation was results reporting to clinicians due to delays at the local laboratory.
Conclusions
This service evaluation provides real‐world evidence that home waking salivary cortisone is an effective, practical screening test for adrenal insufficiency. It identified key barriers to testing implementation that need to be addressed when introducing the test to a health service.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
- Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
- Medical Statistics and Health Economics, School of Health and Related Research, University of Sheffield, Sheffield, UK.
- Department of Biochemistry, Manchester University NHS Foundation Manchester, Manchester, UK.
ORCID-Profile: Charlotte Elder, Richard Ross
Förderung
- Medical Research Council
- Department of Health
Zitieren
APA
Debono, M., Caunt, S., Elder, C., Fearnside, J., Lewis, J., Keevil, B., Dixon, S., & Ross, R. (2023). Real world evidence supports waking salivary cortisone as a screening test for adrenal insufficiency. Clinical Endocrinology. https://doi.org/10.1111/cen.14975
Vancouver
Debono M, Caunt S, Elder C, Fearnside J, Lewis J, Keevil B, et al. Real world evidence supports waking salivary cortisone as a screening test for adrenal insufficiency. Clinical Endocrinology. 2023. doi:10.1111/cen.14975
BibTeX
@article{Debono2023,
author = {Debono, Miguel and Caunt, Sharon and Elder, Charlotte and Fearnside, Jane and Lewis, Jen and Keevil, Brian and Dixon, Simon and Ross, Richard},
title = {Real world evidence supports waking salivary cortisone as a screening test for adrenal insufficiency},
journal = {Clinical Endocrinology},
year = {2023},
doi = {10.1111/cen.14975}
}
EUVIMED